2020
Dapagliflozin reduces the risk of hyperkalaemia in patients with heart failure and reduced ejection fraction: a secondary analysis DAPA-HF
Kristensen S, Docherty K, Jhund P, Bengtsson O, Demets D, Inzucchi S, Kober L, Kosiborod M, Langkilde A, Martinez F, Ponikowski P, Sabatine M, Sjostrand M, Solomon S, McMurray J. Dapagliflozin reduces the risk of hyperkalaemia in patients with heart failure and reduced ejection fraction: a secondary analysis DAPA-HF. European Heart Journal 2020, 41: ehaa946.0939. DOI: 10.1093/ehjci/ehaa946.0939.Peer-Reviewed Original ResearchMineralocorticoid receptor antagonistsRisk of hyperkalaemiaReduced ejection fractionSevere hyperkalaemiaMild hyperkalaemiaDAPA-HFHazard ratioEjection fractionHeart failureMRA useSodium-glucose cotransporter 2 inhibitor dapagliflozinDAPA-HF studyHeart Failure TrialCox regression analysisLife-saving therapyInhibitor dapagliflozinFailure TrialAdverse outcomesReceptor antagonistHyperkalaemiaPatientsDapagliflozinTreatment assignmentHFrEFPlacebo
2017
Obstructive uropathy as initial presentation of genitourinary tuberculosis and masquerading as a postsurgical complication
Igiraneza G, Hategekimana T, Manzi OM, Ogbuagu O. Obstructive uropathy as initial presentation of genitourinary tuberculosis and masquerading as a postsurgical complication. BMJ Case Reports 2017, 2017: bcr-2017-221270. PMID: 29038191, PMCID: PMC5652372, DOI: 10.1136/bcr-2017-221270.Peer-Reviewed Case Reports and Technical NotesConceptsUreteric obstructionGenitourinary tuberculosisSignificant unintentional weight lossDistal ureteric obstructionWeeks of nauseaAcute kidney injuryLower abdominal painTotal abdominal hysterectomyUnintentional weight lossAcid-fast bacilliAbdominal hysterectomy proceduresGeneXpert testAbdominal hysterectomyAbdominal painAntitubercular treatmentKidney injuryBilateral hydronephrosisSevere hyperkalaemiaUreteric injuryInitial presentationMonth historyPostsurgical complicationsUrological interventionLeft ureterUrinary output
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply